Tema Oncology ETF (CANC)
NASDAQ: CANC
· Real-Time Price · USD
26.69
-0.01 (-0.06%)
At close: Aug 18, 2025, 3:58 PM
26.69
0.00%
After-hours: Aug 18, 2025, 04:10 PM EDT
CANC Holdings List
As of Aug 12, 2025
The Tema Oncology ETF is an equity ETF with a total of 52 individual holdings.
The top holdings are BridgeBio Pharma at 5.19%, Roche at 4.86%, Revolution Medicines at 4.75%, Merus at 4.47%, and Astrazeneca plc at 4.23%.
52
42.70%
Equity
69.2M
25.13
0.7500%
Sector Allocation
| Rank | Symbol | Name | Price | % Change | Shares | % Weight |
|---|---|---|---|---|---|---|
| 1 | BBIO | BridgeBio Pharm... | 49.05 | -4.41% | 74.06K | 5.19% |
| 2 | RHHBY | Roche Holding A... | 39.63 | +0.13% | 84.41K | 4.86% |
| 3 | RVMD | Revolution Medi... | 36.47 | +0.41% | 90.29K | 4.75% |
| 4 | MRUS | Merus N.V. | 66.05 | -1.79% | 46.46K | 4.47% |
| 5 | AZN.L | Astrazeneca plc | n/a | n/a | 19.14K | 4.23% |
| 6 | SMMT | Summit Therapeu... | 26.28 | -1.54% | 97.01K | 4.18% |
| 7 | NOVN.SW | Novartis ag | n/a | n/a | 23.89K | 4.18% |
| 8 | GMAB | Genmab A/S | 23.41 | +0.45% | 118.09K | 3.81% |
| 9 | LLY | Eli Lilly and C... | 698.85 | -0.34% | 3.82K | 3.60% |
| 10 | EXEL | Exelixis, Inc. | 37.79 | -1.36% | 60.43K | 3.43% |
| 11 | BMY | Bristol-Myers S... | 48.20 | -0.49% | 48.81K | 3.37% |
| 12 | ACLX | Arcellx, Inc. | 71.60 | -3.35% | 30.74K | 3.26% |
| 13 | NUVL | Nuvalent, Inc. | 75.03 | -1.33% | 28.82K | 3.21% |
| 14 | ZLAB | Zai Lab Limited | 35.67 | -0.17% | 58.52K | 3.08% |
| 15 | ONC | BeOne Medicines... | 319.12 | -0.7% | 7K | 3.04% |
| 16 | ABBV | AbbVie Inc. | 206.48 | -0.1% | 9.63K | 2.87% |
| 17 | LEGN | Legend Biotech ... | 37.47 | -0.08% | 51.42K | 2.86% |
| 18 | AMGN | Amgen Inc. | 292.57 | -1.32% | 5.47K | 2.37% |
| 19 | MRK | Merck & Co., In... | 84.22 | +0.01% | 18.37K | 2.23% |
| 20 | IDYA | IDEAYA Bioscien... | 24.73 | +1.66% | 63.21K | 2.20% |
| 21 | GILD | Gilead Sciences... | 117.99 | -0.32% | 10.14K | 1.82% |
| 22 | ARGX | argenx SE | 660.85 | +1.07% | 1.66K | 1.65% |
| 23 | 4568.T | Daiichi sankyo ... | n/a | n/a | 42.48K | 1.54% |
| 24 | IMNM | Immunome, Inc. | 10.26 | -0.24% | 104.69K | 1.53% |
| 25 | SNDX | Syndax Pharmace... | 15.88 | +0.92% | 78.28K | 1.47% |
| 26 | REGN | Regeneron Pharm... | 573.95 | -1.11% | 1.71K | 1.45% |
| 27 | CELC | Celcuity Inc. | 51.55 | -0.46% | 20.77K | 1.43% |
| 28 | COGT | Cogent Bioscien... | 12.11 | +1.85% | 84.77K | 1.40% |
| 29 | JANX | Janux Therapeut... | 25.50 | +1.55% | 38.05K | 1.31% |
| 30 | NRIX | Nurix Therapeut... | 10.21 | -3.54% | 73.58K | 1.09% |
| 31 | ZYME | Zymeworks Inc. | 14.09 | -1.92% | 60.02K | 1.08% |
| 32 | CGON | CG Oncology, In... | 26.15 | +1.75% | 28.5K | 1.06% |
| 33 | IMCR | Immunocore Hold... | 32.35 | -1.61% | 20.15K | 0.97% |
| 34 | 4519.T | Chugai pharmace... | n/a | n/a | 14.78K | 0.92% |
| 35 | AAPG | Ascentage Pharm... | 47.48 | +5.53% | 14.06K | 0.90% |
| 36 | HCM | HUTCHMED (China... | 16.43 | -0.12% | 38.62K | 0.87% |
| 37 | Cash & cash equ... | n/a | n/a | 0 | 0.79% | |
| 38 | GH | Guardant Health... | 59.45 | +0.96% | 9.71K | 0.79% |
| 39 | ELVN | Enliven Therape... | 19.75 | -2.32% | 29.55K | 0.79% |
| 40 | URGN | UroGen Pharma L... | 19.42 | -1.47% | 27.94K | 0.75% |
| 41 | RCUS | Arcus Bioscienc... | 10.46 | +0.67% | 54.13K | 0.74% |
| 42 | IOVA | Iovance Biother... | 2.49 | -2.35% | 163.9K | 0.52% |
| 43 | SDGR | Schrödinger, In... | 20.05 | +3.46% | 15.87K | 0.46% |
| 44 | NUVB | Nuvation Bio In... | 2.89 | +5.09% | 126.66K | 0.44% |
| 45 | RLAY | Relay Therapeut... | 3.48 | -1.55% | 88.11K | 0.43% |
| 46 | CGEM | Cullinan Oncolo... | 7.95 | +3.79% | 38.72K | 0.42% |
| 47 | ILMN | Illumina, Inc. | 100.53 | +0.41% | 2.97K | 0.42% |
| 48 | DAWN | Day One Biophar... | 6.82 | +1.04% | 43.07K | 0.40% |
| 49 | AUTL | Autolus Therape... | 1.88 | +5.34% | 109.18K | 0.38% |
| 50 | ARVN | Arvinas, Inc. | 7.17 | +1.06% | 36.6K | 0.35% |
| 51 | ANAB | AnaptysBio, Inc... | 20.03 | -0.55% | 10.35K | 0.33% |
| 52 | REPL | Replimune Group... | 5.32 | -4.32% | 40.5K | 0.32% |